Elon Musk’s The Wall Street Journal (WSJ) has cited unnamed sources who express concerns over Musk’s drug consumption
Elon Musk, the high-profile CEO of Tesla and SpaceX, has recently come under scrutiny as reports surface about his alleged use of drugs and its impact on the leadership teams at both companies.
Concerns have been raised among executives and board members at companies led by Elon Musk due to his reported use of drugs, according to sources cited by the Wall Street Journal. The billionaire has allegedly used substances such as LSD, cocaine, ecstasy, and psychedelic mushrooms, often at private gatherings, with ongoing drug use, including ketamine, as per individuals familiar with the matter. Musk had previously stated in August that he holds a prescription for ketamine, using it as an antidepressant.
The Reported Drug Use
According to the WSJ, Elon Musk has been associated with the use of various substances, including LSD, cocaine, ecstasy, and psychedelic mushrooms. These activities are said to have occurred primarily at private events. The report also indicates that Musk’s drug use is an ongoing concern for those close to him, with a specific mention of his consumption of ketamine.
The saga began in September when Musk participated in a lengthy two-and-a-half-hour podcast with Joe Rogan. During the unconventional interview, the duo smoked marijuana, consumed whiskey, and delved into philosophical discussions, with Musk expressing his thoughts on the possibility of humanity existing in a simulated reality. The peculiar conversation occurred during a period of Musk’s erratic behavior, including a tearful interview with The New York Times, revealing personal turmoil.
One noteworthy detail highlighted in the WSJ report is Musk’s reported use of ketamine, a powerful anesthetic that has gained attention for its potential therapeutic effects, particularly in mental health. Musk, in August, publicly acknowledged having a prescription for ketamine, stating that he uses it as an antidepressant. However, the WSJ’s sources suggest that concerns persist among leaders at Tesla and SpaceX regarding the ongoing use of such substances by their CEO.
Impact on Leadership and Company Culture
The revelation of Musk’s alleged drug use raises questions about its potential impact on the leadership and company culture at Tesla and SpaceX. Business leaders are expected to set an example for their teams, and concerns about drug use at the executive level can create a challenging work environment.
The use of certain substances, especially in a professional context, may have legal and regulatory implications. Companies, particularly those in highly regulated industries like aerospace and automotive, often need to adhere to strict standards. Musk’s reported drug use could lead to increased scrutiny from regulators and impact the reputation of both Tesla and SpaceX.
Recent reports suggest that Musk’s security clearance is now under review by the Pentagon. However, both SpaceX and the Department of Defense have remained tight-lipped about the matter. The Department of Defense stated that it is following standard procedures when information that may impact an individual’s clearance eligibility comes to light. The agency refrained from disclosing specifics due to privacy and security reasons.
Musk’s Response and Future Implications
Elon Musk has previously been known for his controversial statements and actions, often utilizing social media to communicate with the public. As this news circulates, the response from Musk and the companies’ official statements will be closely monitored. The revelations could have implications for Tesla and SpaceX’s stock prices, public perception, and Musk’s standing as a business leader.
Conclusion
As Elon Musk navigates various controversies, including his podcast appearance, Twitter usage, and SEC battles, the Pentagon’s review of his security clearance adds another layer of complexity to his situation. The outcome of this review remains uncertain, and stakeholders, investors, and the public will be watching closely to see how these developments impact Musk’s standing in the business and regulatory spheres.
